新的充电胆酶抑制剂:设计,合成和表征
Milena Mlakić1, Danijela Barić2, Ana Ratković3
1Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Trg Marka Marulića 19, HR-10 000 Zagreb, Croatia.
Molecules (Basel, Switzerland)
|April 13, 2024
概括
新的三盐和纳夫托/丁三醇被合成并测试了胆酶抑制. 几种化合物对乙胆酶 (AChE) 和丁胆酶 (BChE) 具有出色的活性,具有治疗神经退行性疾病的潜力.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 酶抑制可以抑制酶.
背景情况:
- 三醇和三盐在药物结构中很常见.
- 1,2,3-triazole衍生物正在被探索用于针对胆酶酶的神经退行性疾病.
- 以前的研究发现了有前途的纳夫托和丁子三醇.
研究的目的:
- 合成和评估新的纳夫托和丁三醇和1,2,3-三盐.
- 评估它们对乙胆酶 (AChE) 和丁胆酶 (BChE) 的抑制潜力.
- 研究它们的物理化学特性,包括光和DNA相互作用.
主要方法:
- 新型纳夫托和丁三醇 (化合物23-34) 和1,2,3-三盐 (化合物44-51) 的合成.
- 对 AChE 和 BChE 的酶抑制试验.
- 对度特性进行光谱分析.
- 在研究包括分子对接和基因毒性评估.
主要成果:
- 44-46号三盐表现出极好的ACHE/BChE抑制;47号和49号盐表现出非常好的抑制.
- 中性光产品 (例如,24-27) 显示出对BCHE的选择性,具有良好的抑制.
- 化合物45和50表现出强烈的光 (斯托克斯转移>160nm) 和蛋白质结合,但没有DNA相互作用.
- 分子对接表明,-π相互作用稳定了酶-连接体复合体.
结论:
- 合成的三盐是胆酶的强有力的抑制剂,显示出治疗相关神经退行性疾病的前景.
- 这些化合物具有独特的光物理特性和蛋白质结合能力.
- 在 silico 研究通过预测有利的相互作用和评估安全性概况来支持它们的潜在治疗应用.
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
556
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
556
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Anticholinesterase Agents: Poisoning and Treatment
851
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
851
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.1K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
953
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
953
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
663
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
663


